S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

INDP Indaptus Therapeutics Inc

0.91

-0.025 (-2.67%)

Jan 31 2025 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics (NASDAQ:INDP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Indaptus Therapeutics Charts.

Indaptus Therapeutics Inc News

Form 8-K - Current report
Friday 31 January 2025 (2 days ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Wednesday 22 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Monday 13 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
Wednesday 8 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
Friday 22 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Tuesday 12 November 2024 (3 months ago) • GlobeNewswire Inc.

Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
Monday 11 November 2024 (3 months ago) • GlobeNewswire Inc.

More Indaptus Therapeutics Inc News Articles

Xtrackers MSCI Pacific e...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions